Literature DB >> 27642202

Managing the Endogenous Risk of Disease Outbreaks with Non-Constant Background Risk.

Kevin Berry1, David Finnoff1, Richard D Horan2, Jason F Shogren1.   

Abstract

There is a growing concern that risks of disease outbreak and pandemics are increasing over time. We consider optimal investments in prevention before an outbreak using an endogenous risk approach within an optimal control setting. Using the threat of pandemic influenza as an illustrative example, we demonstrate that prevention expenditures are relatively small in comparison to the potential losses facing the USA, and these expenditures need to be flexible and responsive to changes in background risk. Failure to adjust these expenditures to changes in background risk poses a significant threat to social welfare into the future.

Entities:  

Keywords:  endogenous risk; infectious disease; optimal control; prevention schedule

Year:  2014        PMID: 27642202      PMCID: PMC5026245          DOI: 10.1016/j.jedc.2014.09.014

Source DB:  PubMed          Journal:  J Econ Dyn Control        ISSN: 0165-1889


  9 in total

1.  Management of infectious wildlife diseases: bridging conventional and bioeconomic approaches.

Authors:  Eli P Fenichel; Richard D Horan; Graham J Hickling
Journal:  Ecol Appl       Date:  2010-06       Impact factor: 4.657

Review 2.  Assessing risks for a pre-emergent pathogen: virginiamycin use and the emergence of streptogramin resistance in Enterococcus faecium.

Authors:  D L Smith; J A Johnson; A D Harris; J P Furuno; E N Perencevich; J G Morris
Journal:  Lancet Infect Dis       Date:  2003-04       Impact factor: 25.071

3.  Risk factors for human disease emergence.

Authors:  L H Taylor; S M Latham; M E Woolhouse
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-07-29       Impact factor: 6.237

Review 4.  Changing patterns of infectious disease.

Authors:  M L Cohen
Journal:  Nature       Date:  2000-08-17       Impact factor: 49.962

Review 5.  The economic impact of pandemic influenza in the United States: priorities for intervention.

Authors:  M I Meltzer; N J Cox; K Fukuda
Journal:  Emerg Infect Dis       Date:  1999 Sep-Oct       Impact factor: 6.883

Review 6.  Prediction and prevention of the next pandemic zoonosis.

Authors:  Stephen S Morse; Jonna A K Mazet; Mark Woolhouse; Colin R Parrish; Dennis Carroll; William B Karesh; Carlos Zambrana-Torrelio; W Ian Lipkin; Peter Daszak
Journal:  Lancet       Date:  2012-12-01       Impact factor: 79.321

7.  Global trends in emerging infectious diseases.

Authors:  Kate E Jones; Nikkita G Patel; Marc A Levy; Adam Storeygard; Deborah Balk; John L Gittleman; Peter Daszak
Journal:  Nature       Date:  2008-02-21       Impact factor: 49.962

Review 8.  The challenge of emerging and re-emerging infectious diseases.

Authors:  David M Morens; Gregory K Folkers; Anthony S Fauci
Journal:  Nature       Date:  2004-07-08       Impact factor: 49.962

9.  Social and environmental risk factors in the emergence of infectious diseases.

Authors:  Robin A Weiss; Anthony J McMichael
Journal:  Nat Med       Date:  2004-12       Impact factor: 53.440

  9 in total
  4 in total

1.  Challenges of integrating economics into epidemiological analysis of and policy responses to emerging infectious diseases.

Authors:  Ciara Dangerfield; Eli P Fenichel; David Finnoff; Nick Hanley; Shaun Hargreaves Heap; Jason F Shogren; Flavio Toxvaerd
Journal:  Epidemics       Date:  2022-05-21       Impact factor: 5.324

2.  Economic Incentives for Managing Filterable Biological Pollution Risks from Trade.

Authors:  Carson Reeling; Richard D Horan
Journal:  Environ Resour Econ (Dordr)       Date:  2017-05-17

3.  The Economic Case for a Pandemic Fund.

Authors:  Kevin Berry; Toph Allen; Richard D Horan; Jason F Shogren; David Finnoff; Peter Daszak
Journal:  Ecohealth       Date:  2018-05-21       Impact factor: 3.184

4.  Investing to Both Prevent and Prepare for COVID-XX.

Authors:  Kevin Berry; Richard D Horan; David Finnoff; Rachel Pompa; Peter Daszak
Journal:  Ecohealth       Date:  2022-03-12       Impact factor: 4.464

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.